PHOSPHODIESTERASE 4B GENETIC VARIANTS ARE NOT ASSOCIATED WITH ANTIPSYCHOTIC-INDUCED TARDIVE DYSKINESIA

被引:0
|
作者
Souza, Renan P. [1 ,2 ]
Remington, Gary [1 ,2 ]
Meltzer, Herbert Y. [3 ]
Lieberman, Jeffrey A. [4 ]
Kennedy, James L. [1 ,2 ]
Wong, Albert H. [1 ,5 ]
机构
[1] Ctr Addict & Mental Hlth, Neurogenet Sect, Toronto, ON, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[3] Vanderbilt Univ, Hosp Psychiat, Nashville, TN USA
[4] Columbia Univ, Med Ctr, New York State Psychiat Inst, New York, NY USA
[5] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada
关键词
D O I
10.1016/j.schres.2010.02.586
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:339 / 339
页数:1
相关论文
共 50 条
  • [41] Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients
    Vaiman, Elena E.
    Shnayder, Natalia A.
    Novitsky, Maxim A.
    Dobrodeeva, Vera S.
    Goncharova, Polina S.
    Bochanova, Elena N.
    Sapronova, Margarita R.
    Popova, Tatiana E.
    Tappakhov, Alexey A.
    Nasyrova, Regina F.
    BIOMEDICINES, 2021, 9 (08)
  • [42] Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials
    Lockwood, Jonathan Tomas
    Remington, Gary
    EXPERT OPINION ON EMERGING DRUGS, 2015, 20 (03) : 407 - 421
  • [43] Thalamotomy for severe antipsychotic induced tardive dyskinesia and dystonia
    Hillier, CEM
    Wiles, CM
    Simpson, BA
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (02): : 250 - 251
  • [44] Antipsychotic-induced life-threatening 'esophageal dyskinesia'
    Horiguchi, J
    Shingu, T
    Hayashi, T
    Kagaya, A
    Yamawaki, S
    Horikawa, Y
    Kitadai, Y
    Inoue, M
    Nishikawa, T
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1999, 14 (02) : 123 - 127
  • [45] A case report of reemergence of antipsychotic-induced dyskinesia with citalopram
    Duggal, Harpreet S.
    Mendhekar, Dattatreya N.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (05) : 803 - 803
  • [46] Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: A meta analysis
    Bakker, PR
    van Harten, PN
    van Os, J
    SCHIZOPHRENIA RESEARCH, 2006, 83 (2-3) : 185 - 192
  • [47] BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: A meta-analysis
    Miura, Itaru
    Zhang, Jian-Ping
    Nitta, Masahiro
    Lencz, Todd
    Kane, John M.
    Malhotra, Anil K.
    Yabe, Hirooki
    Correll, Christoph U.
    SCHIZOPHRENIA RESEARCH, 2014, 152 (2-3) : 365 - 372
  • [48] Pharmacogenetics of antipsychotic induced weight gain and tardive dyskinesia.
    Basile, VS
    Masellis, M
    Ozdemir, V
    Walker, ML
    Meltzer, HY
    Lieberman, JA
    Potkin, SG
    Alva, G
    Kennedy, JL
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2000, 96 (04): : 467 - 467
  • [49] CLINICAL DIFFERENCES BETWEEN METOCLOPRAMIDE-INDUCED AND ANTIPSYCHOTIC-INDUCED TARDIVE DYSKINESIAS
    LANG, AE
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1990, 17 (02) : 137 - 139
  • [50] GENETIC FACTORS ASSOCIATED WITH ANTIPSYCHOTIC-INDUCED WEIGHT GAIN AND CARDIOMETABOLIC RISK
    Nicol, Ginger E.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 61 (10): : S301 - S301